Follow
Joyce Lee
Joyce Lee
Dana-Farber Cancer Institute & Harvard Medical School
Verified email at dfci.harvard.edu
Title
Cited by
Cited by
Year
Cell cycle-dependent control and roles of DNA topoisomerase II
JH Lee, JM Berger
Genes 10 (11), 859, 2019
1212019
Resveratrol: A novel type of topoisomerase II inhibitor
JH Lee, TJ Wendorff, JM Berger
Journal of Biological Chemistry 292 (51), 21011-21022, 2017
552017
Synergistic coordination of chromatin torsional mechanics and topoisomerase activity
TT Le, X Gao, S ha Park, J Lee, JT Inman, JH Lee, JL Killian, RP Badman, ...
Cell 179 (3), 619-631. e15, 2019
462019
Control of topoisomerase II activity and chemotherapeutic inhibition by TCA cycle metabolites
JH Lee, EP Mosher, YS Lee, NN Bumpus, JM Berger
Cell Chemical Biology 29, 1-14, 2021
112021
Understanding the species selectivity of myeloid cell leukemia-1 (Mcl-1) inhibitors
B Zhao, AL Arnold, MA Coronel, JH Lee, T Lee, ET Olejniczak, SW Fesik
Biochemistry 57 (32), 4952-4958, 2018
92018
Etoposide promotes DNA loop trapping and barrier formation by topoisomerase II
TT Le, M Wu, JH Lee, N Bhatt, JT Inman, JM Berger, MD Wang
Nature chemical biology, 1-10, 2023
62023
DNA-stimulated liquid-liquid phase separation by eukaryotic topoisomerase II modulates catalytic function
J Jeong, JH Lee, CC Carcamo, MW Parker, JM Berger
eLife, 2022
32022
Chromatinization modulates topoisomerase II processivity
J Lee, M Wu, JT Inman, G Singh, S Park, JH Lee, RM Fulbright, Y Hong, ...
Nature communications 14 (1), 6844, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–8